Header Logo

Connection

SALIM VIRANI to Risk Factors

Back to Details
This is a "connection" page, showing publications SALIM VIRANI has written about Risk Factors.
SALIM VIRANI
Connection Strength
7.391
Risk Factors
  1. Racial and ethnic disparities in cardiovascular disease - analysis across major US national databases. J Natl Med Assoc. 2024 Jun; 116(3):258-270.
    View in: PubMed
    Score: 0.084
  2. Cardiovascular disease burden in the Middle East and North Africa region. Curr Probl Cardiol. 2024 Mar; 49(3):102341.
    View in: PubMed
    Score: 0.083
  3. Global Cardiovascular Research: Gaps and Opportunities. Curr Cardiol Rep. 2023 12; 25(12):1831-1838.
    View in: PubMed
    Score: 0.082
  4. The underutilization of preventive cardiovascular measures in patients with cancer: an analysis of the Behavioural Risk Factor Surveillance System, 2011-22. Eur J Prev Cardiol. 2023 09 20; 30(13):1325-1332.
    View in: PubMed
    Score: 0.081
  5. Lipoprotein(a) in clinical practice: A guide for the clinician. Prog Cardiovasc Dis. 2023 Jul-Aug; 79:28-36.
    View in: PubMed
    Score: 0.081
  6. The Pandemic of Coronary Heart Disease in South Asia: What Clinicians Need to Know. Curr Atheroscler Rep. 2023 07; 25(7):359-372.
    View in: PubMed
    Score: 0.080
  7. The importance of low-density lipoprotein cholesterol measurement and control as performance measures: A joint Clinical Perspective from the National Lipid Association and the American Society for Preventive Cardiology. J Clin Lipidol. 2023 Mar-Apr; 17(2):208-218.
    View in: PubMed
    Score: 0.078
  8. Gender Differences in Clinical Outcomes After Percutaneous Coronary Intervention-Analysis of 15,106 Patients from the Cardiac Registry of Pakistan Database. Am J Cardiol. 2023 02 01; 188:61-67.
    View in: PubMed
    Score: 0.077
  9. Statin Use and Risk of Diabetes by Subclinical Atherosclerosis Burden (from a Multi-Ethnic Study of Atherosclerosis Report). Am J Cardiol. 2022 12 01; 184:7-13.
    View in: PubMed
    Score: 0.076
  10. Comparing eligibility for statin therapy for primary prevention under 2022 USPSTF recommendations and the 2018 AHA/ACC/ multi-society guideline recommendations: From National Health and Nutrition Examination Survey. Prog Cardiovasc Dis. 2022 Nov-Dec; 75:78-82.
    View in: PubMed
    Score: 0.076
  11. Association of polygenic risk scores with incident atherosclerotic cardiovascular disease events among individuals with coronary artery calcium score of zero: The multi-ethnic study of atherosclerosis. Prog Cardiovasc Dis. 2022 Sep-Oct; 74:19-27.
    View in: PubMed
    Score: 0.075
  12. PCSK9 Inhibitors in the Management of Cardiovascular Risk: A Practical Guidance. Vasc Health Risk Manag. 2022; 18:555-566.
    View in: PubMed
    Score: 0.075
  13. Lipoprotein(a) and ethnicities. Atherosclerosis. 2022 05; 349:42-52.
    View in: PubMed
    Score: 0.074
  14. Readmission in Patients With ST-Elevation Myocardial Infarction in 4 Age Groups (<45, >45 to <60, 60 to <75, and >75). Am J Cardiol. 2022 06 15; 173:25-32.
    View in: PubMed
    Score: 0.074
  15. Association of premature atherosclerotic cardiovascular disease with higher risk of cancer: a behavioral risk factor surveillance system study. Eur J Prev Cardiol. 2022 Mar 25; 29(3):493-501.
    View in: PubMed
    Score: 0.073
  16. Prevalence and Predictors of Premature Coronary Heart Disease Among Asians in the United States: A National Health Interview Survey Study. Curr Probl Cardiol. 2023 Jul; 48(7):101152.
    View in: PubMed
    Score: 0.073
  17. Global think tank on the clinical considerations and management of lipoprotein(a): The top questions and answers regarding what clinicians need to know. Prog Cardiovasc Dis. 2022 Jul-Aug; 73:32-40.
    View in: PubMed
    Score: 0.073
  18. The Utility of Coronary Artery Calcium for Guiding Treatment With Preventive Pharmacotherapy: Opportunities and Nuances. JACC Cardiovasc Imaging. 2022 04; 15(4):652-654.
    View in: PubMed
    Score: 0.072
  19. Association of Coronary Artery Calcium Density and Volume With Predicted Atherosclerotic Cardiovascular Disease Risk and Cardiometabolic Risk Factors in South Asians: The Mediators of Atherosclerosis in South Asians Living in America (MASALA) Study. Curr Probl Cardiol. 2023 Apr; 48(4):101105.
    View in: PubMed
    Score: 0.072
  20. Determinants of Incident Atherosclerotic Cardiovascular Disease Events Among Those With Absent Coronary Artery Calcium: Multi-Ethnic Study of Atherosclerosis. Circulation. 2022 01 25; 145(4):259-267.
    View in: PubMed
    Score: 0.072
  21. Association of patient, provider and facility related characteristics with statin associated side effects and statin use: Insight from the Veteran's Affairs healthcare system. J Clin Lipidol. 2021 Nov-Dec; 15(6):832-839.
    View in: PubMed
    Score: 0.071
  22. Epidemiology and risk factors for stroke in young individuals: implications for prevention. Curr Opin Cardiol. 2021 09 01; 36(5):565-571.
    View in: PubMed
    Score: 0.071
  23. Disease-Specific Excess Mortality During the COVID-19 Pandemic: An Analysis of Weekly US Death Data for 2020. Am J Public Health. 2021 08; 111(8):1518-1522.
    View in: PubMed
    Score: 0.070
  24. Gender Differences in Premature Coronary Artery Disease (from the National Data from the NHANES Database). Am J Cardiol. 2021 08 15; 153:142-144.
    View in: PubMed
    Score: 0.070
  25. Lipoprotein (a): Recent Updates on a Unique Lipoprotein. Curr Atheroscler Rep. 2021 06 19; 23(8):41.
    View in: PubMed
    Score: 0.070
  26. Social Determinants of Health and Comorbidities Among Individuals with Atherosclerotic Cardiovascular Disease: The Behavioral Risk Factor Surveillance System Survey. Popul Health Manag. 2022 02; 25(1):39-45.
    View in: PubMed
    Score: 0.070
  27. Use of oral anticoagulants in patients with valvular atrial fibrillation: findings from the NCDR PINNACLE Registry. Am Heart J. 2021 10; 240:58-62.
    View in: PubMed
    Score: 0.069
  28. Recreational substance use among patients with premature atherosclerotic cardiovascular disease. Heart. 2021 04; 107(8):650-656.
    View in: PubMed
    Score: 0.068
  29. Clinical characteristics and mortality after acute myocardial infarction-related hospitalization among Asians from a national population-based cohort study. Prog Cardiovasc Dis. 2021 Jul-Aug; 67:108-110.
    View in: PubMed
    Score: 0.068
  30. Heart Disease and Stroke Statistics-2021 Update: A Report From the American Heart Association. Circulation. 2021 02 23; 143(8):e254-e743.
    View in: PubMed
    Score: 0.068
  31. Racial disparities among Asian Americans with atrial fibrillation: An analysis from the NCDR? PINNACLE Registry. Int J Cardiol. 2021 04 15; 329:209-216.
    View in: PubMed
    Score: 0.068
  32. Pathophysiological Mechanisms Underlying Excess Risk for Diabetes and Cardiovascular Disease in South Asians: The Perfect Storm. Curr Diabetes Rev. 2021; 17(9):e070320183447.
    View in: PubMed
    Score: 0.067
  33. Distribution of calcium volume, density, number, and type of coronary vessel with calcified plaque in South Asians in the US and other race/ethnic groups: The MASALA and MESA studies. Atherosclerosis. 2021 01; 317:16-21.
    View in: PubMed
    Score: 0.067
  34. Statin Prescription Rates, Adherence, and Associated Clinical Outcomes Among Women with PAD and ICVD. Cardiovasc Drugs Ther. 2020 12; 34(6):745-754.
    View in: PubMed
    Score: 0.066
  35. Premature Atherosclerotic Cardiovascular Disease: What Have We Learned Recently? Curr Atheroscler Rep. 2020 07 16; 22(9):44.
    View in: PubMed
    Score: 0.065
  36. Effect of heart failure on the outcome of COVID-19 - A meta analysis and systematic review. Am J Emerg Med. 2021 Aug; 46:204-211.
    View in: PubMed
    Score: 0.065
  37. Autoimmune Rheumatic Diseases and Premature Atherosclerotic Cardiovascular Disease: An Analysis From the VITAL Registry. Am J Med. 2020 12; 133(12):1424-1432.e1.
    View in: PubMed
    Score: 0.065
  38. The Use of Sex-Specific Factors in the Assessment of Women's Cardiovascular Risk. Circulation. 2020 02 18; 141(7):592-599.
    View in: PubMed
    Score: 0.064
  39. High-Sensitivity C-Reactive Protein Discordance With Atherogenic Lipid Measures and Incidence of Atherosclerotic Cardiovascular Disease in Primary Prevention: The ARIC Study. J Am Heart Assoc. 2020 02 04; 9(3):e013600.
    View in: PubMed
    Score: 0.063
  40. Heart Disease and Stroke Statistics-2020 Update: A Report From the American Heart Association. Circulation. 2020 03 03; 141(9):e139-e596.
    View in: PubMed
    Score: 0.063
  41. Cardiovascular Disease Prevention in Focus: Highlights from the 2019 American Heart Association Scientific Sessions. Curr Atheroscler Rep. 2020 01 11; 22(1):3.
    View in: PubMed
    Score: 0.063
  42. Spotlight on Icosapent Ethyl for Cardiovascular Risk Reduction: Evidence to Date. Vasc Health Risk Manag. 2020; 16:1-10.
    View in: PubMed
    Score: 0.063
  43. Coronary Artery Calcification, Statin Use and Long-Term Risk of Atherosclerotic Cardiovascular Disease Events (from the Multi-Ethnic Study of Atherosclerosis). Am J Cardiol. 2020 03 15; 125(6):835-839.
    View in: PubMed
    Score: 0.063
  44. Highlights from Selected Cardiovascular Disease Prevention Studies Presented at the 2019 European Society of Cardiology Congress. Curr Atheroscler Rep. 2019 11 19; 21(12):46.
    View in: PubMed
    Score: 0.062
  45. Very High-Risk ASCVD and Eligibility for Nonstatin Therapies Based on the 2018?AHA/ACC Cholesterol Guidelines. J Am Coll Cardiol. 2019 08 06; 74(5):712-714.
    View in: PubMed
    Score: 0.061
  46. Cardio-metabolic disease risk factors among South Asian labour migrants to the Middle East: a scoping review and policy analysis. Global Health. 2019 05 02; 15(1):33.
    View in: PubMed
    Score: 0.060
  47. 2018 Cholesterol Guidelines: Key Topics in Primary Prevention. Curr Atheroscler Rep. 2019 03 16; 21(5):17.
    View in: PubMed
    Score: 0.060
  48. Eligibility and Cost for Icosapent Ethyl Based on the REDUCE-IT Trial. Circulation. 2019 03 05; 139(10):1341-1343.
    View in: PubMed
    Score: 0.059
  49. Socio-economic inequalities in hypertension burden and cascade of services: nationwide cross-sectional study in Nepal. J Hum Hypertens. 2019 08; 33(8):613-625.
    View in: PubMed
    Score: 0.059
  50. Association of Body Mass Index With Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Cardiovascular Disease. Circ Cardiovasc Qual Outcomes. 2019 01; 12(1):e004817.
    View in: PubMed
    Score: 0.059
  51. Favorable Modifiable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs Among Cancer Patients: The 2012-2013 Medical Expenditure Panel Survey. J Am Heart Assoc. 2018 04 23; 7(9).
    View in: PubMed
    Score: 0.056
  52. Premature Coronary Heart Disease in South Asians: Burden and Determinants. Curr Atheroscler Rep. 2018 01 27; 20(1):6.
    View in: PubMed
    Score: 0.055
  53. Lipoprotein(a) and cardiovascular disease: current state and future directions for an enigmatic lipoprotein. Front Biosci (Landmark Ed). 2018 01 01; 23(6):1099-1112.
    View in: PubMed
    Score: 0.055
  54. Associations of Lipoprotein(a) Levels With Incident Atrial Fibrillation and Ischemic Stroke: The ARIC (Atherosclerosis Risk in Communities) Study. J Am Heart Assoc. 2017 Dec 15; 6(12).
    View in: PubMed
    Score: 0.055
  55. Association Between Modifiable Risk Factors and Pharmaceutical Expenditures Among Adults With Atherosclerotic Cardiovascular Disease in the United States: 2012-2013 Medical Expenditures Panel?Survey. J Am Heart Assoc. 2017 Jun 09; 6(6).
    View in: PubMed
    Score: 0.053
  56. Overview of Coronary Heart Disease Risk Initiatives in South Asia. Curr Atheroscler Rep. 2017 Jun; 19(6):25.
    View in: PubMed
    Score: 0.053
  57. Mobile Health (mHealth) Technology for the Management of Hypertension and Hyperlipidemia: Slow Start but Loads of Potential. Curr Atheroscler Rep. 2017 Mar; 19(3):12.
    View in: PubMed
    Score: 0.052
  58. From Plaque Burden to Plaque Composition: Toward?Personalized Risk?Assessment. JACC Cardiovasc Imaging. 2017 03; 10(3):250-252.
    View in: PubMed
    Score: 0.052
  59. Aspirin reduces cardiovascular events in primary prevention of cardiovascular disease but at a near equivalent risk of increased bleeding. Evid Based Med. 2016 12; 21(6):225.
    View in: PubMed
    Score: 0.050
  60. Harder-to-Treat Patients: Recognizing Them and Adapting Treatment Strategies. Am J Cardiol. 2016 Sep 15; 118(6 Suppl):13A-8A.
    View in: PubMed
    Score: 0.050
  61. The 2013 ACC/AHA Cholesterol Management Guideline: Clearing the Confusion from Noncontroversial Components. Tex Heart Inst J. 2016 Aug; 43(4):313-4.
    View in: PubMed
    Score: 0.050
  62. Risk Factor Optimization and Guideline-Directed Medical Therapy in US Veterans With Peripheral Arterial and Ischemic Cerebrovascular Disease Compared to Veterans With Coronary Heart Disease. Am J Cardiol. 2016 Oct 15; 118(8):1144-1149.
    View in: PubMed
    Score: 0.050
  63. Guideline-Directed Medication Use in Patients With Heart Failure With Reduced Ejection Fraction in India: American College of Cardiology's PINNACLE India Quality Improvement Program. Clin Cardiol. 2016 Mar; 39(3):145-9.
    View in: PubMed
    Score: 0.048
  64. Case-based educational intervention to assess change in providers' knowledge and attitudes towards the 2013 American College of Cardiology/American Heart Association Cholesterol Management Guideline. Atherosclerosis. 2016 Mar; 246:115-20.
    View in: PubMed
    Score: 0.048
  65. Coronary artery disease performance measures and statin use in patients with recent percutaneous coronary intervention or recent coronary artery bypass grafting (from the NCDR PINNACLE registry). Am J Cardiol. 2015 Apr 15; 115(8):1013-8.
    View in: PubMed
    Score: 0.045
  66. Frequency and practice-level variation in inappropriate aspirin use for the primary prevention of cardiovascular disease: insights from the National Cardiovascular Disease Registry's Practice Innovation and Clinical Excellence registry. J Am Coll Cardiol. 2015 Jan 20; 65(2):111-21.
    View in: PubMed
    Score: 0.045
  67. Association of body mass index and waist circumference with subclinical atherosclerosis in retired NFL players. South Med J. 2014 Oct; 107(10):633-9.
    View in: PubMed
    Score: 0.044
  68. Relation between playing position and coronary artery calcium scores in retired National Football League players. Am J Cardiol. 2014 Dec 15; 114(12):1836-40.
    View in: PubMed
    Score: 0.044
  69. What is new in the 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic risk in adults? Tex Heart Inst J. 2014 Jun; 41(3):304-5.
    View in: PubMed
    Score: 0.043
  70. Neck circumference is not associated with subclinical atherosclerosis in retired National Football League players. Clin Cardiol. 2014 Jul; 37(7):402-7.
    View in: PubMed
    Score: 0.042
  71. Correlates of repeat lipid testing in patients with coronary heart disease. JAMA Intern Med. 2013 Aug 12; 173(15):1439-44.
    View in: PubMed
    Score: 0.040
  72. Statins in the primary and secondary prevention of cardiovascular disease in women: facts and myths. Tex Heart Inst J. 2013; 40(3):288-9.
    View in: PubMed
    Score: 0.039
  73. Association between statins and infections after coronary artery bypass grafting. Int J Cardiol. 2013 Sep 20; 168(1):117-20.
    View in: PubMed
    Score: 0.038
  74. Outcomes of preoperative angiotensin-converting enzyme inhibitor therapy in patients undergoing isolated coronary artery bypass grafting. Am J Cardiol. 2012 Oct 01; 110(7):919-23.
    View in: PubMed
    Score: 0.037
  75. Association between traditional cholesterol parameters, lipoprotein particle concentration, novel biomarkers and carotid plaques in retired National Football League players. Atherosclerosis. 2012 Jun; 222(2):551-6.
    View in: PubMed
    Score: 0.037
  76. Chromosome 9p21 single nucleotide polymorphisms are not associated with recurrent myocardial infarction in patients with established coronary artery disease. Circ J. 2012; 76(4):950-6.
    View in: PubMed
    Score: 0.036
  77. Association of gender with morbidity and mortality after isolated coronary artery bypass grafting. A propensity score matched analysis. Int J Cardiol. 2013 Jul 15; 167(1):180-4.
    View in: PubMed
    Score: 0.036
  78. Relation of cholesterol and lipoprotein parameters with carotid artery plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) carotid MRI study. Atherosclerosis. 2011 Dec; 219(2):596-602.
    View in: PubMed
    Score: 0.035
  79. Isolated coronary artery bypass grafting in obese individuals: a propensity matched analysis of outcomes. Circ J. 2011; 75(6):1378-85.
    View in: PubMed
    Score: 0.034
  80. Non-HDL cholesterol as a metric of good quality of care: opportunities and challenges. Tex Heart Inst J. 2011; 38(2):160-2.
    View in: PubMed
    Score: 0.034
  81. Relationship between circulating levels of RANTES (regulated on activation, normal T-cell expressed, and secreted) and carotid plaque characteristics: the Atherosclerosis Risk in Communities (ARIC) Carotid MRI Study. Eur Heart J. 2011 Feb; 32(4):459-68.
    View in: PubMed
    Score: 0.033
  82. Preoperative statin therapy decreases risk of postoperative renal insufficiency. Cardiovasc Ther. 2010 Apr; 28(2):80-6.
    View in: PubMed
    Score: 0.032
  83. Obesity: an independent predictor of in-hospital postoperative renal insufficiency among patients undergoing cardiac surgery? Tex Heart Inst J. 2009; 36(6):540-5.
    View in: PubMed
    Score: 0.029
  84. Preoperative statin therapy is not associated with a decrease in the incidence of postoperative atrial fibrillation in patients undergoing cardiac surgery. Am Heart J. 2008 Mar; 155(3):541-6.
    View in: PubMed
    Score: 0.027
  85. The role of lipoprotein-associated phospholipase A2 as a marker for atherosclerosis. Curr Atheroscler Rep. 2007 Aug; 9(2):97-103.
    View in: PubMed
    Score: 0.027
  86. Left main coronary artery stenosis: factors predicting cardiac events in patients awaiting coronary surgery. Tex Heart Inst J. 2006; 33(1):23-6.
    View in: PubMed
    Score: 0.024
  87. Burden of cardiometabolic diseases and depression in a low-income, urban community in Pakistan: a cross-sectional survey. BMC Public Health. 2025 Feb 24; 25(1):757.
    View in: PubMed
    Score: 0.022
  88. Early-onset atherosclerotic cardiovascular disease. Eur J Prev Cardiol. 2025 Jan 27; 32(2):100-112.
    View in: PubMed
    Score: 0.022
  89. Interdisciplinary perspectives on the co-management of metabolic dysfunction-associated steatotic liver disease and coronary artery disease. Lancet Gastroenterol Hepatol. 2025 Jan; 10(1):82-94.
    View in: PubMed
    Score: 0.022
  90. Trends in Cardiovascular Disease-Related Mortality in Texas. Tex Heart Inst J. 2024 Jul-Dec; 51(2):e248426.
    View in: PubMed
    Score: 0.022
  91. Clonal hematopoiesis of indeterminate potential and cardiovascular disease: Pathogenesis, clinical presentation, and future directions. Prog Cardiovasc Dis. 2024 Sep-Oct; 86:79-85.
    View in: PubMed
    Score: 0.022
  92. Predictors of incident stroke among individuals without coronary artery calcification: A pooled cohort analysis from the Multi-Ethnic Study of Atherosclerosis, Jackson Heart Study, and Framingham Heart Study. Vasc Med. 2024 Dec; 29(6):632-639.
    View in: PubMed
    Score: 0.022
  93. Trajectory of C-Reactive Protein and Incident Heart Failure in Black Adults: The Jackson Heart Study. Circ Heart Fail. 2024 Aug; 17(8):e011199.
    View in: PubMed
    Score: 0.022
  94. Relationship between race, income-level, and Cardiovascular Disease. J Natl Med Assoc. 2024 Oct; 116(5):539-552.
    View in: PubMed
    Score: 0.022
  95. Interaction between risk factors, coronary calcium, and CCTA plaque characteristics in patients aged 18-45 years. Eur Heart J Cardiovasc Imaging. 2024 Jul 31; 25(8):1071-1082.
    View in: PubMed
    Score: 0.022
  96. Going from Primary to Primordial Prevention: Is the Juice Worth the Squeeze? Curr Cardiol Rep. 2024 Oct; 26(10):1135-1143.
    View in: PubMed
    Score: 0.022
  97. Global burden of cardiovascular disease attributable to smoking, 1990-2019: an analysis of the 2019 Global Burden of Disease Study. Eur J Prev Cardiol. 2024 Jul 23; 31(9):1123-1131.
    View in: PubMed
    Score: 0.022
  98. Presentation, management, and early outcomes of young acute coronary syndrome patients- analysis of 23,560 South Asian patients from 2012 to 2021. BMC Cardiovasc Disord. 2024 07 19; 24(1):378.
    View in: PubMed
    Score: 0.022
  99. The Role of Sleep in Cardiovascular Disease. Curr Atheroscler Rep. 2024 Jul; 26(7):249-262.
    View in: PubMed
    Score: 0.021
  100. Association of High-Density Lipoprotein Parameters and Risk of Heart?Failure: A Multicohort Analysis. JACC Heart Fail. 2024 Jul; 12(7):1242-1253.
    View in: PubMed
    Score: 0.021
  101. Cardiovascular Health and Disease in the Pakistani American Population. Curr Atheroscler Rep. 2024 06; 26(6):205-215.
    View in: PubMed
    Score: 0.021
  102. Epidemiology and Prognostic Implications of Coronary Artery Calcium in Asymptomatic Individuals With Prediabetes: A Multicohort Study. Diabetes Care. 2024 Apr 01; 47(4):698-706.
    View in: PubMed
    Score: 0.021
  103. Association of cardiovascular health with subclinical coronary atherosclerosis progression among five racial and ethnic groups: The MASALA and MESA studies. Atherosclerosis. 2024 05; 392:117522.
    View in: PubMed
    Score: 0.021
  104. Association of cardiometabolic and vascular atherosclerosis phenotypes on non-contrast chest CT with incident heart failure in patients with severe hypercholesterolemia. J Clin Lipidol. 2024 May-Jun; 18(3):e403-e412.
    View in: PubMed
    Score: 0.021
  105. Association of cardiovascular risk profile with premature all-cause and cardiovascular mortality in US adults: findings from a national study. BMC Cardiovasc Disord. 2024 02 06; 24(1):91.
    View in: PubMed
    Score: 0.021
  106. Long-Term Mortality in Patients With Severe Hypercholesterolemia Phenotype From a Racial and Ethnically Diverse US Cohort. Circulation. 2024 02 06; 149(6):417-426.
    View in: PubMed
    Score: 0.021
  107. Development and Validation of the American Heart Association's PREVENT Equations. Circulation. 2024 02 06; 149(6):430-449.
    View in: PubMed
    Score: 0.021
  108. Novel Prediction Equations for Absolute Risk Assessment of Total Cardiovascular Disease Incorporating Cardiovascular-Kidney-Metabolic Health: A Scientific Statement From the American Heart Association. Circulation. 2023 12 12; 148(24):1982-2004.
    View in: PubMed
    Score: 0.021
  109. Association of interleukin-6 and interleukin-18 with cardiovascular disease in older adults: Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2023 11 09; 30(16):1731-1740.
    View in: PubMed
    Score: 0.021
  110. Novel Size-Based High-Density Lipoprotein Subspecies and Incident Vascular Events. J Am Heart Assoc. 2023 11 07; 12(21):e031160.
    View in: PubMed
    Score: 0.021
  111. A Synopsis of the Evidence for the Science and Clinical Management of Cardiovascular-Kidney-Metabolic (CKM) Syndrome: A Scientific Statement From the American Heart Association. Circulation. 2023 11 14; 148(20):1636-1664.
    View in: PubMed
    Score: 0.020
  112. Cardiovascular-Kidney-Metabolic Health: A Presidential Advisory From the American Heart Association. Circulation. 2023 11 14; 148(20):1606-1635.
    View in: PubMed
    Score: 0.020
  113. Interplay Between Zero CAC, Quantitative Plaque Analysis, and Adverse Events in a Diverse Patient Cohort. Circ Cardiovasc Imaging. 2023 08; 16(8):e015236.
    View in: PubMed
    Score: 0.020
  114. Age-Related Differences in the Contribution of Systolic Blood Pressure and Biomarkers to Cardiovascular Disease Risk Prediction: The Atherosclerosis Risk in Communities (ARIC) Study. Am J Cardiol. 2023 10 01; 204:295-301.
    View in: PubMed
    Score: 0.020
  115. Trends and Outcomes of Transcatheter Aortic Valve Implantation in Aortic Insufficiency: A Nationwide Readmission Database Analysis. Curr Probl Cardiol. 2024 Jan; 49(1 Pt A):102012.
    View in: PubMed
    Score: 0.020
  116. Prevalence of familial hypercholesterolemia in a country-wide laboratory network in Pakistan: 10-year data from 988, 306 patients. Prog Cardiovasc Dis. 2023 Jul-Aug; 79:19-27.
    View in: PubMed
    Score: 0.020
  117. Medical Management of Coronary Artery Disease in Patients with Chronic Kidney Disease. Am J Med. 2023 12; 136(12):1147-1159.
    View in: PubMed
    Score: 0.020
  118. Integrative Genetic Approach Facilitates Precision Strategies for Acute Myocardial Infarction. Genes (Basel). 2023 06 26; 14(7).
    View in: PubMed
    Score: 0.020
  119. Celiac Disease and the Risk of Cardiovascular Diseases. Int J Mol Sci. 2023 Jun 09; 24(12).
    View in: PubMed
    Score: 0.020
  120. Low educational attainment is associated with higher all-cause and cardiovascular mortality in the United States adult population. BMC Public Health. 2023 05 16; 23(1):900.
    View in: PubMed
    Score: 0.020
  121. Predictors of Non-Obstructive Coronary Artery Disease in Patients Undergoing Elective Coronary Angiography. Glob Heart. 2023; 18(1):26.
    View in: PubMed
    Score: 0.020
  122. Frequent questions and responses on the 2022 lipoprotein(a) consensus statement of the European Atherosclerosis Society. Atherosclerosis. 2023 06; 374:107-120.
    View in: PubMed
    Score: 0.020
  123. Number of Live Births, Age at the Time of Having a Child, Span of Births and Risk of Dementia: A Population-Based Cohort Study of 253,611?U.K. Women. J Womens Health (Larchmt). 2023 06; 32(6):680-692.
    View in: PubMed
    Score: 0.020
  124. The Effect of Yoga on Cardiovascular Disease Risk Factors: A Meta-Analysis. Curr Probl Cardiol. 2023 May; 48(5):101593.
    View in: PubMed
    Score: 0.019
  125. Family income and cardiovascular disease risk in American adults. Sci Rep. 2023 01 06; 13(1):279.
    View in: PubMed
    Score: 0.019
  126. Temporal Trends in Lipoprotein(a) Concentrations: The Atherosclerosis Risk in Communities Study. J Am Heart Assoc. 2022 11; 11(21):e026762.
    View in: PubMed
    Score: 0.019
  127. Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement. Eur Heart J. 2022 10 14; 43(39):3925-3946.
    View in: PubMed
    Score: 0.019
  128. Association between remnant lipoprotein cholesterol, high-sensitivity C-reactive protein, and risk of atherosclerotic cardiovascular disease events in the Multi-Ethnic Study of Atherosclerosis (MESA). J Clin Lipidol. 2022 Nov-Dec; 16(6):870-877.
    View in: PubMed
    Score: 0.019
  129. Identifying Differences: A Key Step in Precision Cardiovascular Disease Prevention. J Am Heart Assoc. 2022 08 02; 11(15):e026600.
    View in: PubMed
    Score: 0.019
  130. Alcohol Consumption and Cardiovascular Health. Am J Med. 2022 10; 135(10):1213-1230.e3.
    View in: PubMed
    Score: 0.019
  131. Sex differences in the association between cardiovascular diseases and dementia subtypes: a prospective analysis of 464,616 UK Biobank participants. Biol Sex Differ. 2022 05 07; 13(1):21.
    View in: PubMed
    Score: 0.019
  132. Burden of cardiovascular risk factors and disease in five Asian groups in Catalonia: a disaggregated, population-based analysis of 121?000 first-generation Asian immigrants. Eur J Prev Cardiol. 2022 05 06; 29(6):916-924.
    View in: PubMed
    Score: 0.019
  133. Midlife determinants of healthy cardiovascular aging: The Atherosclerosis Risk in Communities (ARIC) study. Atherosclerosis. 2022 06; 350:82-89.
    View in: PubMed
    Score: 0.018
  134. Reducing Cardiovascular Risk in the Medicare Million Hearts Risk Reduction Model: Insights From the National Cardiovascular Data Registry PINNACLE Registry. Circ Cardiovasc Qual Outcomes. 2022 04; 15(4):e007908.
    View in: PubMed
    Score: 0.018
  135. Independent Association of Lipoprotein(a) and Coronary Artery Calcification With Atherosclerotic Cardiovascular Risk. J Am Coll Cardiol. 2022 03 01; 79(8):757-768.
    View in: PubMed
    Score: 0.018
  136. Social Determinants of Health Among Non-Elderly Adults With Stroke in the United States. Mayo Clin Proc. 2022 02; 97(2):238-249.
    View in: PubMed
    Score: 0.018
  137. Heart Disease and Stroke Statistics-2022 Update: A Report From the American Heart Association. Circulation. 2022 02 22; 145(8):e153-e639.
    View in: PubMed
    Score: 0.018
  138. Clinical and Economic Burden of Percutaneous Coronary Intervention in Hospitalized Young Adults in the United States, 2004-2018. Curr Probl Cardiol. 2022 Nov; 47(11):101070.
    View in: PubMed
    Score: 0.018
  139. Burden of chronic kidney disease in the general population and high-risk groups in South Asia: A systematic review and meta-analysis. PLoS One. 2021; 16(10):e0258494.
    View in: PubMed
    Score: 0.018
  140. Assessment of Coronary Artery Calcium Scoring to Guide Statin Therapy Allocation According to Risk-Enhancing Factors: The Multi-Ethnic Study of Atherosclerosis. JAMA Cardiol. 2021 10 01; 6(10):1161-1170.
    View in: PubMed
    Score: 0.018
  141. Cardiovascular Disease Risk-Based Statin Utilization and Associated Outcomes in a Primary Prevention Cohort: Insights From a Large Health Care Network. Circ Cardiovasc Qual Outcomes. 2021 09; 14(9):e007485.
    View in: PubMed
    Score: 0.018
  142. Trends in Characteristics and Outcomes of Hospitalized Young Patients Undergoing Coronary Artery Bypass Grafting in the United States, 2004 to 2018. J Am Heart Assoc. 2021 09 07; 10(17):e021361.
    View in: PubMed
    Score: 0.018
  143. Scope and Social Determinants of Food Insecurity Among Adults With Atherosclerotic Cardiovascular Disease in the United States. J Am Heart Assoc. 2021 08 17; 10(16):e020028.
    View in: PubMed
    Score: 0.018
  144. Association between circulating Galectin-3 and arterial stiffness in older adults. Vasa. 2021 Nov; 50(6):439-445.
    View in: PubMed
    Score: 0.018
  145. Social Determinants of Health and Cardiovascular Disease: Current State and Future Directions Towards Healthcare Equity. Curr Atheroscler Rep. 2021 07 26; 23(9):55.
    View in: PubMed
    Score: 0.018
  146. Lipid Monitoring After Initiation of Lipid-Lowering Therapies: Return of Performance Measures? Curr Cardiol Rep. 2021 07 16; 23(9):116.
    View in: PubMed
    Score: 0.018
  147. Meta-analysis comparing valve-in-valve TAVR and redo-SAVR in patients with degenerated bioprosthetic aortic valve. Catheter Cardiovasc Interv. 2021 11 01; 98(5):940-947.
    View in: PubMed
    Score: 0.017
  148. Transatlantic guidelines on dyslipidemia and cardiovascular risk: key differences across the pond. Curr Opin Endocrinol Diabetes Obes. 2021 04 01; 28(2):114-121.
    View in: PubMed
    Score: 0.017
  149. Association of NT-ProBNP, Blood Pressure, and Cardiovascular Events: The ARIC Study. J Am Coll Cardiol. 2021 02 09; 77(5):559-571.
    View in: PubMed
    Score: 0.017
  150. Predictors of In-Hospital Mortality in Patients With End-Stage Renal Disease Undergoing Transcatheter Aortic Valve Replacement: A Nationwide Inpatient Sample Database Analysis. Cardiovasc Revasc Med. 2022 01; 34:63-68.
    View in: PubMed
    Score: 0.017
  151. Percutaneous coronary intervention in patients with cardiac allograft vasculopathy: a Nationwide Inpatient Sample (NIS) database analysis. Expert Rev Cardiovasc Ther. 2021 Mar; 19(3):269-276.
    View in: PubMed
    Score: 0.017
  152. Soluble Angiotensin-Converting Enzyme 2, Cardiac Biomarkers, Structure, and Function, and Cardiovascular Events (from the Atherosclerosis Risk in Communities Study). Am J Cardiol. 2021 05 01; 146:15-21.
    View in: PubMed
    Score: 0.017
  153. Patient-Perceived Versus Actual Risk of Cardiovascular Disease and Associated Willingness to Consider and Use Prevention Therapy. Circ Cardiovasc Qual Outcomes. 2021 01; 14(1):e006548.
    View in: PubMed
    Score: 0.017
  154. Dyslipidemia and Cardiovascular Disease Prevention in South Asians: A Review and Discussion of Causes, Challenges and Management Strategies. Curr Diabetes Rev. 2021; 17(9):e011221190238.
    View in: PubMed
    Score: 0.017
  155. Trends and Predictors of Transcatheter Aortic Valve Implantation Related In-Hospital Mortality (From the National Inpatient Sample Database). Am J Cardiol. 2021 03 15; 143:97-103.
    View in: PubMed
    Score: 0.017
  156. Plasma Dehydroepiandrosterone Sulfate and Cardiovascular Disease Risk in Older Men and Women. J Clin Endocrinol Metab. 2020 12 01; 105(12).
    View in: PubMed
    Score: 0.017
  157. Telomere length in young patients with acute myocardial infarction without conventional risk factors: A pilot study from a South Asian population. Indian Heart J. 2020 Nov-Dec; 72(6):619-622.
    View in: PubMed
    Score: 0.017
  158. Sex Differences in the Age of Diagnosis for Cardiovascular Disease and Its Risk Factors Among US Adults: Trends From 2008 to 2017, the Medical Expenditure Panel Survey. J Am Heart Assoc. 2020 12 15; 9(24):e018764.
    View in: PubMed
    Score: 0.017
  159. Revascularization Practices and Outcomes in Patients With Multivessel Coronary Artery Disease Who Presented With Acute Myocardial Infarction and Cardiogenic Shock in the US, 2009-2018. JAMA Intern Med. 2020 10 01; 180(10):1317-1327.
    View in: PubMed
    Score: 0.017
  160. Coronavirus disease-19 and cardiovascular disease: A risk factor or a risk marker? Rev Med Virol. 2021 05; 31(3):e2172.
    View in: PubMed
    Score: 0.017
  161. Cardiorespiratory Fitness and Incident Stroke Types: The FIT (Henry Ford ExercIse Testing) Project. Mayo Clin Proc. 2020 07; 95(7):1379-1389.
    View in: PubMed
    Score: 0.016
  162. Meditation and Cardiovascular Health in the US. Am J Cardiol. 2020 09 15; 131:23-26.
    View in: PubMed
    Score: 0.016
  163. Temporal Trends in Percutaneous Coronary?Intervention and Coronary Artery Bypass Grafting: Insights From the Washington Cardiac Care Outcomes Assessment Program. J Am Heart Assoc. 2020 06 02; 9(11):e015317.
    View in: PubMed
    Score: 0.016
  164. The relationship between cardiorespiratory fitness, cardiovascular risk factors and atherosclerosis. Atherosclerosis. 2020 07; 304:44-52.
    View in: PubMed
    Score: 0.016
  165. Beliefs, risk perceptions, and lipid management among patients with and without diabetes: Results from the PALM registry. Am Heart J. 2020 07; 225:88-96.
    View in: PubMed
    Score: 0.016
  166. Burden and Consequences of Financial Hardship From Medical Bills Among Nonelderly Adults With Diabetes Mellitus in the United States. Circ Cardiovasc Qual Outcomes. 2020 02; 13(2):e006139.
    View in: PubMed
    Score: 0.016
  167. Association Between Poverty and Appropriate Statin Prescription for the Treatment of Hyperlipidemia in the United States: An Analysis From the ACC NCDR PINNACLE Registry. Cardiovasc Revasc Med. 2020 08; 21(8):1016-1021.
    View in: PubMed
    Score: 0.016
  168. Medical Therapy Utilization and Long-Term Outcomes Following Percutaneous Coronary Intervention: Five-Year Results From the Veterans Affairs Clinical Assessment, Reporting, and Tracking System Program. Circ Cardiovasc Qual Outcomes. 2019 11; 12(11):e005455.
    View in: PubMed
    Score: 0.016
  169. Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM Registry. J Am Heart Assoc. 2019 10; 8(19):e013229.
    View in: PubMed
    Score: 0.015
  170. Effect of increasing age on percutaneous coronary intervention vs coronary artery bypass grafting in older adults with unprotected left main coronary artery disease: A meta-analysis and meta-regression. Clin Cardiol. 2019 Nov; 42(11):1071-1078.
    View in: PubMed
    Score: 0.015
  171. Sex Differences in the Use of Statins in Community Practice. Circ Cardiovasc Qual Outcomes. 2019 08; 12(8):e005562.
    View in: PubMed
    Score: 0.015
  172. Total cholesterol/HDL-cholesterol ratio discordance with LDL-cholesterol and non-HDL-cholesterol and incidence of atherosclerotic cardiovascular disease in primary prevention: The ARIC study. Eur J Prev Cardiol. 2020 10; 27(15):1597-1605.
    View in: PubMed
    Score: 0.015
  173. Primary and Secondary Prevention of Cardiovascular Disease in Patients with Chronic Kidney Disease. Curr Atheroscler Rep. 2019 06 22; 21(9):32.
    View in: PubMed
    Score: 0.015
  174. Subsequent Event Risk in Individuals With Established Coronary Heart Disease. Circ Genom Precis Med. 2019 04; 12(4):e002470.
    View in: PubMed
    Score: 0.015
  175. Association of Chromosome 9p21 With Subsequent Coronary Heart Disease Events. Circ Genom Precis Med. 2019 04; 12(4):e002471.
    View in: PubMed
    Score: 0.015
  176. Heart Disease and Stroke Statistics-2019 Update: A Report From the American Heart Association. Circulation. 2019 03 05; 139(10):e56-e528.
    View in: PubMed
    Score: 0.015
  177. Risk Assessment of Stroke in Patients with Atrial Fibrillation: Current Shortcomings and Future Directions. Cardiovasc Drugs Ther. 2019 02; 33(1):105-117.
    View in: PubMed
    Score: 0.015
  178. Lipoprotein(a) levels and risk of cardiovascular disease events in individuals with diabetes mellitus or prediabetes: The Atherosclerosis Risk in Communities study. Atherosclerosis. 2019 03; 282:52-56.
    View in: PubMed
    Score: 0.015
  179. Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and Preferences. JAMA Cardiol. 2018 12 01; 3(12):1192-1199.
    View in: PubMed
    Score: 0.015
  180. Use of Risk Assessment Tools to?Guide?Decision-Making in the?Primary?Prevention of Atherosclerotic?Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. J Am Coll Cardiol. 2019 06 25; 73(24):3153-3167.
    View in: PubMed
    Score: 0.015
  181. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 06 18; 139(25):e1046-e1081.
    View in: PubMed
    Score: 0.015
  182. Use of Risk Assessment Tools to Guide Decision-Making in the Primary Prevention of Atherosclerotic Cardiovascular Disease: A Special Report From the American Heart Association and American College of Cardiology. Circulation. 2019 06 18; 139(25):e1162-e1177.
    View in: PubMed
    Score: 0.015
  183. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. Circulation. 2019 06 18; 139(25):e1082-e1143.
    View in: PubMed
    Score: 0.015
  184. Are All Benefits and Harms Equal? J Am Coll Cardiol. 2018 08 14; 72(7):819-820.
    View in: PubMed
    Score: 0.014
  185. Statin Eligibility, Coronary Artery Calcium, and Subsequent Cardiovascular Events According to the 2016 United States Preventive Services Task Force (USPSTF) Statin Guidelines: MESA (Multi-Ethnic Study of Atherosclerosis). J Am Heart Assoc. 2018 06 13; 7(12).
    View in: PubMed
    Score: 0.014
  186. Life's Simple 7 and the risk of atrial fibrillation: The Multi-Ethnic Study of Atherosclerosis. Atherosclerosis. 2018 08; 275:174-181.
    View in: PubMed
    Score: 0.014
  187. Statin Use and Adverse Effects Among Adults >75?Years of Age: Insights From the Patient and Provider Assessment of Lipid Management (PALM) Registry. J Am Heart Assoc. 2018 05 08; 7(10).
    View in: PubMed
    Score: 0.014
  188. High-density lipoprotein cholesterol and causes of death in chronic kidney disease. J Clin Lipidol. 2018 Jul - Aug; 12(4):1061-1071.e7.
    View in: PubMed
    Score: 0.014
  189. Short-Term Global Cardiovascular Disease Risk?Prediction in Older Adults. J Am Coll Cardiol. 2018 06 05; 71(22):2527-2536.
    View in: PubMed
    Score: 0.014
  190. Prevalence and Management of Symptoms Associated With Statin Therapy in Community Practice: Insights From the PALM (Patient and Provider Assessment of Lipid Management) Registry. Circ Cardiovasc Qual Outcomes. 2018 03; 11(3):e004249.
    View in: PubMed
    Score: 0.014
  191. Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018 03 20; 137(12):e67-e492.
    View in: PubMed
    Score: 0.014
  192. National Trends in Nonstatin Use and Expenditures Among the US Adult Population From 2002 to 2013: Insights From Medical Expenditure Panel?Survey. J Am Heart Assoc. 2018 01 22; 7(2).
    View in: PubMed
    Score: 0.014
  193. Persistent socioeconomic disparities in cardiovascular risk factors and health in the United States: Medical Expenditure Panel Survey 2002-2013. Atherosclerosis. 2018 02; 269:301-305.
    View in: PubMed
    Score: 0.014
  194. Clinical pharmacist understanding of the 2013 American College of Cardiology/American Heart Association cholesterol guideline. J Clin Lipidol. 2018 Mar - Apr; 12(2):367-374.e3.
    View in: PubMed
    Score: 0.014
  195. Association of low-density lipoprotein pattern with mortality after myocardial infarction: Insights from the TRIUMPH study. J Clin Lipidol. 2017 Nov - Dec; 11(6):1458-1470.e4.
    View in: PubMed
    Score: 0.013
  196. Use of cardiopulmonary pump support during coronary artery bypass grafting in the high-risk: a meta-analysis. Ir J Med Sci. 2018 May; 187(2):369-377.
    View in: PubMed
    Score: 0.013
  197. Life's Simple 7 and Incident Heart Failure: The Multi-Ethnic Study of Atherosclerosis. J Am Heart Assoc. 2017 Jun 27; 6(6).
    View in: PubMed
    Score: 0.013
  198. Relations between lipoprotein(a) concentrations, LPA genetic variants, and the risk of mortality in patients with established coronary heart disease: a molecular and genetic association study. Lancet Diabetes Endocrinol. 2017 07; 5(7):534-543.
    View in: PubMed
    Score: 0.013
  199. The association of lipoprotein(a) with incident heart failure hospitalization: Atherosclerosis Risk in Communities study. Atherosclerosis. 2017 07; 262:131-137.
    View in: PubMed
    Score: 0.013
  200. Patient-Provider Communication and Health Outcomes Among Individuals With Atherosclerotic Cardiovascular Disease in the United States: Medical Expenditure Panel Survey 2010 to 2013. Circ Cardiovasc Qual Outcomes. 2017 04; 10(4).
    View in: PubMed
    Score: 0.013
  201. Factors associated with rhythm control treatment decisions in patients with atrial fibrillation-Insights from the NCDR PINNACLE registry. Am Heart J. 2017 May; 187:88-97.
    View in: PubMed
    Score: 0.013
  202. Favorable cardiovascular risk factor profile is associated with lower healthcare expenditure and resource utilization among adults with diabetes mellitus free of established cardiovascular disease: 2012 Medical Expenditure Panel Survey (MEPS). Atherosclerosis. 2017 03; 258:79-83.
    View in: PubMed
    Score: 0.013
  203. BNP and obesity in acute decompensated heart failure with preserved vs. reduced ejection fraction: The Atherosclerosis Risk in Communities Surveillance Study. Int J Cardiol. 2017 Apr 15; 233:61-66.
    View in: PubMed
    Score: 0.013
  204. Association between high-sensitivity troponin T and cardiovascular risk in individuals with and without metabolic syndrome: The ARIC study. Eur J Prev Cardiol. 2017 04; 24(6):628-638.
    View in: PubMed
    Score: 0.013
  205. Antihypertensive adherence and outcomes among community-dwelling Medicare beneficiaries: the Atherosclerosis Risk in Communities Study. J Eval Clin Pract. 2018 02; 24(1):48-55.
    View in: PubMed
    Score: 0.013
  206. Magnetic Resonance Venous Volume Measurements in Peripheral Artery Disease (from ELIMIT). Am J Cardiol. 2016 Nov 01; 118(9):1399-1404.
    View in: PubMed
    Score: 0.012
  207. Cardiovascular disease risk by assigned treatment using the 2013 and 1998 obesity guidelines. Obesity (Silver Spring). 2016 07; 24(7):1554-60.
    View in: PubMed
    Score: 0.012
  208. A Systematic Review of the Prevalence and Outcomes of Ideal Cardiovascular Health in US?and Non-US Populations. Mayo Clin Proc. 2016 05; 91(5):649-70.
    View in: PubMed
    Score: 0.012
  209. Favorable Cardiovascular Risk Profile Is Associated With Lower Healthcare Costs and Resource Utilization: The 2012 Medical Expenditure Panel Survey. Circ Cardiovasc Qual Outcomes. 2016 Mar; 9(2):143-53.
    View in: PubMed
    Score: 0.012
  210. The impact of multiple single day blood pressure readings on cardiovascular risk estimation: The Atherosclerosis Risk in Communities study. Eur J Prev Cardiol. 2016 09; 23(14):1529-36.
    View in: PubMed
    Score: 0.012
  211. Trends in Ideal Cardiovascular Health Metrics Among Employees of a Large Healthcare Organization (from the Baptist Health South Florida Employee Study). Am J Cardiol. 2016 Mar 01; 117(5):787-93.
    View in: PubMed
    Score: 0.012
  212. Design and rationale for the Patient and Provider Assessment of Lipid Management (PALM) registry. Am Heart J. 2015 Nov; 170(5):865-71.
    View in: PubMed
    Score: 0.012
  213. Relationship of the triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio to the remainder of the lipid profile: The Very Large Database of Lipids-4 (VLDL-4) study. Atherosclerosis. 2015 Sep; 242(1):243-50.
    View in: PubMed
    Score: 0.012
  214. Implications of the Eighth Joint National Committee Guidelines for the Management of High Blood Pressure for Aging Adults: Atherosclerosis Risk in Communities Study. Hypertension. 2015 Sep; 66(3):474-80.
    View in: PubMed
    Score: 0.012
  215. High-sensitivity troponin T and cardiovascular events in systolic blood pressure categories: atherosclerosis risk in communities study. Hypertension. 2015 Jan; 65(1):78-84.
    View in: PubMed
    Score: 0.011
  216. Perioperative beta blockade in noncardiac surgery: a systematic review for the 2014 ACC/AHA guideline on perioperative cardiovascular evaluation and management of patients undergoing noncardiac surgery: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. Circulation. 2014 Dec 09; 130(24):2246-64.
    View in: PubMed
    Score: 0.011
  217. Acute coronary syndromes: unstable angina and non-ST elevation myocardial infarction. Cardiol Clin. 2014 Aug; 32(3):353-70.
    View in: PubMed
    Score: 0.011
  218. Prognostic significance of hyponatremia among ambulatory patients with heart failure and preserved and reduced ejection fractions. Am J Cardiol. 2014 Jun 01; 113(11):1834-8.
    View in: PubMed
    Score: 0.011
  219. Small dense low-density lipoprotein-cholesterol concentrations predict risk for coronary heart disease: the Atherosclerosis Risk In Communities (ARIC) study. Arterioscler Thromb Vasc Biol. 2014 May; 34(5):1069-77.
    View in: PubMed
    Score: 0.010
  220. Executive summary: heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation. 2014 Jan 21; 129(3):399-410.
    View in: PubMed
    Score: 0.010
  221. Dyslipidemia, coronary artery calcium, and incident atherosclerotic cardiovascular disease: implications for statin therapy from the multi-ethnic study of atherosclerosis. Circulation. 2014 Jan 07; 129(1):77-86.
    View in: PubMed
    Score: 0.010
  222. Troponin T and N-terminal pro-B-type natriuretic peptide: a biomarker approach to predict heart failure risk--the atherosclerosis risk in communities study. Clin Chem. 2013 Dec; 59(12):1802-10.
    View in: PubMed
    Score: 0.010
  223. Ceruloplasmin and heart failure in the Atherosclerosis Risk in Communities study. Circ Heart Fail. 2013 Sep 01; 6(5):936-43.
    View in: PubMed
    Score: 0.010
  224. Cardiovascular biomarkers and subclinical brain disease in the atherosclerosis risk in communities study. Stroke. 2013 Jul; 44(7):1803-8.
    View in: PubMed
    Score: 0.010
  225. Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation. 2013 Jan 01; 127(1):e6-e245.
    View in: PubMed
    Score: 0.010
  226. Apolipoproteins do not add prognostic information beyond lipoprotein cholesterol measures among individuals with obesity and insulin resistance syndromes: the ARIC study. Eur J Prev Cardiol. 2014 Jul; 21(7):866-75.
    View in: PubMed
    Score: 0.010
  227. A genetic risk score based on direct associations with coronary heart disease improves coronary heart disease risk prediction in the Atherosclerosis Risk in Communities (ARIC), but not in the Rotterdam and Framingham Offspring, Studies. Atherosclerosis. 2012 Aug; 223(2):421-6.
    View in: PubMed
    Score: 0.009
  228. The 9p21 genetic variant is additive to carotid intima media thickness and plaque in improving coronary heart disease risk prediction in white participants of the Atherosclerosis Risk in Communities (ARIC) Study. Atherosclerosis. 2012 May; 222(1):135-7.
    View in: PubMed
    Score: 0.009
  229. Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation. 2012 Jan 03; 125(1):e2-e220.
    View in: PubMed
    Score: 0.009
  230. Subclinical changes in serum creatinine and mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2012 Mar; 143(3):682-688.e1.
    View in: PubMed
    Score: 0.009
  231. Carotid arterial wall characteristics are associated with incident ischemic stroke but not coronary heart disease in the Atherosclerosis Risk in Communities (ARIC) study. Stroke. 2012 Jan; 43(1):103-8.
    View in: PubMed
    Score: 0.009
  232. Cardiac troponin T measured by a highly sensitive assay predicts coronary heart disease, heart failure, and mortality in the Atherosclerosis Risk in Communities Study. Circulation. 2011 Apr 05; 123(13):1367-76.
    View in: PubMed
    Score: 0.009
  233. Lipid management: considerations in acute coronary syndrome. Curr Cardiol Rep. 2008 Jul; 10(4):334-41.
    View in: PubMed
    Score: 0.007
  234. Noncardiac surgery following percutaneous coronary intervention. Catheter Cardiovasc Interv. 2004 Nov; 63(3):267-73.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.